Design, Synthesis, and In-silico Evaluation of Quinazoline Derivatives as Anti-Inflammatory Agents

Researchers are now investigating quinazoline derivatives, which are a group of chemicals with diverse biological effects, in order to find powerful anti-inflammatory drugs. Developing and analysing novel quinazoline compounds that precisely target the 4JQA protein—a critical component of the inflammatory response—is the main goal of this study. The study will involve designing and synthesising these compounds, as well as evaluating their effectiveness using computer simulations. A number of quinazoline derivatives were synthesised by employing rational drug design ideas and synthetic chemistry methods many spectroscopic methods, such as NMR, were used to confirm the structures of the synthesised molecules. Afterward, the anti-inflammatory capabilities of these compounds were assessed using molecular docking experiments against the 4JQA protein. The docking investigations demonstrated that a number of the synthesized quinazoline derivatives had robust binding affinities and advantageous interactions with the active region of the 4JQA protein. Significant interactions with amino acid residues essential for the protein's activity were detected, indicating a potential mode of action for these chemicals as anti-inflammatory drugs. The encouraging findings from the computational docking studies establish a strong basis for subsequent laboratory and animal experiments, facilitating the progress toward creating innovative quinazoline-based medicines with anti-inflammatory properties. This study emphasizes the potential benefits of integrating computational and experimental approaches in developing new drugs, namely in the search for and development of innovative therapeutic drugs that target pathways linked with inflammation.